| PERIOD ENDING | 30-Sep-08 | | Total Revenue | 427 | | Cost of Revenue | 308 | | | Gross Profit | 119 | | | Operating Expenses | | Research Development | 289 | | Selling General and Administrative | 1,825 | | Non Recurring |
-
| | Others | 50 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (2,045) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19) | | Earnings Before Interest And Taxes | (2,064) | | Interest Expense | 19 | | Income Before Tax | (2,083) | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | (2,083) | | | Non-recurring Events | | Discontinued Operations | (25) | | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (2,108) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($2,108) |
|
1.48% Nasdaq 
Income Statement
